EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 263 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2018. The put-call ratio across all filers is 1.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $5,000 | -16.7% | 90 | 0.0% | 0.00% | – |
Q2 2021 | $6,000 | -93.5% | 90 | -91.0% | 0.00% | -100.0% |
Q1 2021 | $92,000 | 0.0% | 998 | -3.1% | 0.01% | -14.3% |
Q4 2020 | $92,000 | -4.2% | 1,030 | +10.0% | 0.01% | -12.5% |
Q3 2020 | $96,000 | +4.3% | 936 | -19.9% | 0.01% | 0.0% |
Q2 2020 | $92,000 | +21.1% | 1,168 | -10.8% | 0.01% | 0.0% |
Q1 2020 | $76,000 | -5.0% | 1,310 | -12.2% | 0.01% | +14.3% |
Q4 2019 | $80,000 | -20.0% | 1,492 | -22.4% | 0.01% | -30.0% |
Q3 2019 | $100,000 | -28.1% | 1,922 | -33.4% | 0.01% | -28.6% |
Q2 2019 | $139,000 | -2.1% | 2,884 | +2.6% | 0.01% | -6.7% |
Q1 2019 | $142,000 | -2.1% | 2,812 | +15.0% | 0.02% | -11.8% |
Q4 2018 | $145,000 | +237.2% | 2,446 | +272.9% | 0.02% | +240.0% |
Q3 2018 | $43,000 | +30.3% | 656 | 0.0% | 0.01% | +25.0% |
Q2 2018 | $33,000 | -8.3% | 656 | -4.1% | 0.00% | 0.0% |
Q1 2018 | $36,000 | +3500.0% | 684 | +3320.0% | 0.00% | – |
Q4 2017 | $1,000 | – | 20 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Values First Advisors, Inc. | 152,699 | $519,178 | 0.34% |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 299,187 | $1,017,000 | 0.22% |
Hilltop Holdings Inc. | 235,019 | $799,064 | 0.09% |
AIMZ Investment Advisors, LLC | 51,372 | $174,665 | 0.08% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 868,605 | $2,953,257 | 0.07% |
PALISADE CAPITAL MANAGEMENT, LP | 509,325 | $1,731,705 | 0.05% |
SHERBROOKE PARK ADVISERS LLC | 41,417 | $140,818 | 0.04% |
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 2,428,490 | $8,256,866 | 0.03% |
Y-Intercept (Hong Kong) Ltd | 75,362 | $256,231 | 0.02% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,246,020 | $4,236,468 | 0.02% |